Prospective Study
Copyright ©The Author(s) 2025.
World J Methodol. Jun 20, 2025; 15(2): 98143
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.98143
Table 4 Comparative analysis of hematological-derived indices among non-ST segment elevation myocardial infarction patients with major adverse cardiovascular event with lethal and non-lethal outcome, median (25th-75th percentiles)
HDR
Time
Lethal outcome (n = 35)
Non-lethal outcome (n = 51)
P value
NLRT17.432 (4.542-12.551)3.816 (2.423-5.783)< 0.001
T26.934 (3.672-12.165)2.794 (2.167-5.580)< 0.001
dNLRT13.955 (2.721-6.764)2.618 (1.667-3.675)0.009
T23.142 (2.056-5.686)2.124 (1.436-3.295)0.027
NPRT10.032 (0.028-0.045)0.030 (0.023-0.038)0.090
T20.031 (0.026-0.053)0.026 (0.018-0.038)0.047
NLPRT10.029 (0.021-0.043)0.016 (0.011-0.030)0.005
T20.035 (0.017-0.056)0.013 (0.009-0.028)< 0.001
PLRT1238.000 (150.420-303.448)124.887 (92.446-191.566)0.007
T2195.349 (149.359-353.846)122.619 (83.529-169.186)0.001
MNRT10.067 (0.054-0.107)0.111 (0.072-0.144)0.028
T20.074 (0.043-0.112)0.131 (0.099-0.172)0.000
MLRT10.609 (0.424-0.892)0.365 (0.272-0.509)0.008
T20.559 (0.428-0.756)0.417 (0.282-0.553)0.028
LMRT11.641 (1.121-2.358)2.742 (1.966-3.681)0.008
T21.788 (1.324-2.337)2.400 (1.808-3.549)0.028
LCRT10.047 (0.015-0.163)0.371 (0.084-0.748)0.001
T20.027 (0.008-0.102)0.151 (0.027-0.424)0.002
CRP/LyT121.145 (6.137-66.303)2.321 (1.327-10.517)0.001
T237.403 (9.790-121.186)6.630 (2.361-37.340)0.002
SIIT11812.658 (950.655-3283.542)919.518 (561.464-1277.483)0.001
T21778.563 (852.908-2800.333)673.179 (413.184-1362.656)0.001
AISIT11399.338 (695.922-2265.644)536.824 (370.566-910.278)0.003
T21353.896 (625.428-1836.498)473.738 (293.227-1110.313)0.011
SIRIT14.511 (2.677-9.560)2.473 (1.565-3.845)0.003
T24.653 (2.639-9.270)2.244 (1.482-4.164)0.009

  • Citation: Bećirović E, Bećirović M, Šegalo S, Bećirović A, Hadžić S, Ljuca K, Papić E, Ferhatbegović L, Ejubović M, Jagodić Ejubović A, Kovčić A, Šljivo A, Begagić E. Hemogram-derived ratios as prognostic markers for major adverse cardiovascular events in patients with non-ST-segment elevation myocardial infarction. World J Methodol 2025; 15(2): 98143
  • URL: https://www.wjgnet.com/2222-0682/full/v15/i2/98143.htm
  • DOI: https://dx.doi.org/10.5662/wjm.v15.i2.98143